Phase I/II Trial of S65487 Plus Azacitidine in Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Acute Myeloid Leukemia
Related studies linked through entity extraction aliases.
A Study of CFI-400945 With or Without Azacitidine in Patients With AML, MDS or CMML
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
PD-1 Inhibitor Combined With Azacytidine and Homoharringtonine，Cytarabine, G-CSF for Refractory or Relapsed AML
- Status
- UNKNOWN
- Phase
- PHASE3
FT538 in Combination With Daratumumab in AML Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Prognostic Value of CD318 in AML at Assiut University Hospital.
- Status
- UNKNOWN
- Phase
- N/A
Venetoclax to Improve Outcomes of Fractionated Busulfan Regimen in Patients With High-Risk AML and MDS
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
TAA6 Cell Injection In The Treatment of Patients With Relapsed / Refractory Acute Myeloid Leukemia
- Status
- UNKNOWN
- Phase
- NA
Minimal Residual Disease Evaluation on Cryopreserved Ovarian Fragments in Younger Patients Treated for Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- N/A
Flotetuzumab Expanded Access Program
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Daunorubicin or Idarubicin With Cytarabine Plus Quizartinib vs Physician's Choice in Newly Diagnosed FLT3-ITD+ AML
- Status
- WITHDRAWN
- Phase
- PHASE3
A Post-treatment Program to Identify and Manage Complications Related to Oncology or Hematology Treatments in Cancer Survivors.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
PTCy and Ruxolitinib vs PTCy, Tacrolimus and MMF in MUD and Haploidentical HSCT
- Status
- COMPLETED
- Phase
- PHASE2
TL-895 and KRT-232 Study in Acute Myeloid Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
SARS-CoV-2 Donor-Recipient Immunity Transfer
- Status
- COMPLETED
- Phase
- N/A
CD 70 CAR T for Patients With CD70 Positive Malignant Hematologic Diseases
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Pemigatinib After Chemotherapy for the Treatment of Newly Diagnosed Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- PHASE1
NKG2D CAR-T Cell Therapy for Patients With Relapsed and/or Refractory Acute Myeloid Leukemia
- Status
- NOT_YET_RECRUITING
- Phase
- EARLY_PHASE1
Pharmacokinetics, Safety, and Efficacy of ASTX727 in Combination With Venetoclax in Acute Myeloid Leukemia (AML)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
National Longitudinal Cohort of Hematological Diseases
- Status
- RECRUITING
- Phase
- N/A